Keywords
How to Cite
Abstract
Annotatsiya: Ushbu maqola kasalxona ichida tarqaluvchi yuqumli kasalliklar (Gospital infeksiyalar, GI) qo'zg'atuvchilari orasida opportunistik patogenlarning rolini tahlil qiladi. Opportunistik infeksiyalar odatda immunitet tizimi zaiflashgan bemorlarda uchraydi va kasallikning og'irlashuviga, statsionar davolanish muddatining uzayishiga hamda o'lim darajasining oshishiga olib keladi. Maqolada GI ning keng tarqalgan opportunistik qo'zg'atuvchilari, ularning patogenlik mexanizmlari va kasallikning rivojlanishidagi o'rni ko'rib chiqiladi. Shuningdek, ushbu infeksiyalarni aniqlash va samarali oldini olish bo'yicha mavjud va yangi diagnostik hamda terapevtik strategiyalar muhokama qilinadi. Antibiotiklarga chidamlilikning ortib borayotgan muammosi ham e'tiborga olinib, uning oldini olishga qaratilgan tadbirlarning ahamiyati ta'kidlanadi. Tadqiqot natijalari kasalxona sharoitida GI ning oldini olish va nazorat qilish bo'yicha muhim ma'lumotlar beradi.
References
1. World Health Organization. (2020). Global report on the epidemiology and prevention of antimicrobial resistance. Geneva: WHO.
2. Magiorakos, A. P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., ... & Paterson, D. L. (2014). Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an updated definition and classification. International journal of antimicrobial agents, 43(6), 481-492.
3. Lister, P. D., & Françoise, J. (2016). Acinetobacter baumannii: mechanism of virulence and resistance. Virulence, 7(3), 237-244.
4. Pfaller, M. A., & Diekema, D. J. (2010). Rare and emerging opportunistic pathogens: a continuing challenge for infectious disease clinicians. Journal of clinical microbiology, 48(10), 3553-3559.
5. Vincent, J. L., De Backer, D., & Neve, G. (2018). Nosocomial infections. Critical Care, 22(1), 1-11.
6. Peleg, A. Y., Seifert, H., & Paterson, D. L. (2008). Multi-drug-resistant Acinetobacter baumannii: emergence, definition, and treatment. Emerging infectious diseases, 14(7), 1013.
7. Kafil, H. S., & Mansouri, F. (2018). Nosocomial infections in Iran: A systematic review and meta-analysis. Infection, Drug Resistance, 11, 587.
8. Bassetti, M., Viale, P., Schlattmann, P., Palami, C., & Recchia, F. (2018). Epidemiology and risk factors for carbapenem-resistant Klebsiella pneumoniae. Clinical microbiology and infection, 24(7), 730-735.
9. Shorr, A. F., & Tabak, Y. P. (2014). The burden of healthcare-associated infections. Current opinion in infectious diseases, 27(4), 342-347.
10. Tacconelli, E., Carrara, E., Filippini, C., Corbellino, M., & Gualano, M. R. (2017). Antimicrobial resistance: the global challenge. European journal of public health, 27(suppl_3), 17-22.
11. Paul, G., Singh, R., & Singh, S. (2020). Current strategies for the management of nosocomial infections. Journal of clinical and diagnostic research, 14(6), DC01.
12. Hossain, S. F., Islam, M. S., & Rahman, M. M. (2021). Emerging trends of multidrug-resistant pathogens in hospital-acquired infections. Frontiers in Microbiology, 12, 674982.
13. Luz, C. M., & da Silva, W. D. (2019). Diagnostic methods for opportunistic infections in hospitalized patients. Expert review of anti-infective therapy, 17(10), 745-758.
14. Peña, C., Río-Vázquez, J. L., & Aranzazu, M. P. (2019). Prevention and control of healthcare-associated infections: a systematic review of best practices. Antibiotics, 8(3), 108.
15. Hughes, D. (2017). The antimicrobial resistance crisis. Nature Reviews Microbiology, 15(4), 220-221.
This work is licensed under a Creative Commons Attribution 4.0 International License.